FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

39303711000001102: Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71591000001119 Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71601000001111 Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has specific active ingredient Trastuzumab true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has specific active ingredient Pertuzumab true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Is a Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Is a Phesgo true Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) 1 vial Has AMP True Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start